1Charpentier C,Audibert G,Guillemin F,et al.Multivariate analysis of predictors of cerebral vasospasm occurrence after aneurysmal subarachnoid hemorrhage.Stroke,1999,30:1402-1408.
2Rabinstein AA,Friedman JA,Weigand SD,et al.Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage.Stroke,2004,35:1862-1866.
3Macdonald RL,Rosengart A,Huo D,et al.Factors associated with the development of vasospasm after planned surgical treatment of aneurysmal subarachnoid hemorrhage.J Neurosurg,2003,99:644 -652.
4Park KW,Metais C,Dai HB,et al.Microvascular endothelial dysfunction and its mechanism a rat model of subarachnoid hemorrhage.Anesth Aalg,2001,92:990 -996.
5Onoue H,Tsutsui M,Smith L,et al.Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery after experimental subarachnoid hemorrhage.Stroke,1998,29:1959 -1965.
6Zimmermann M.Endothelin in cerebral vasospasm.Clinical and experimental results.J Neurosurg,1997,41:139-151.
7Mascia L,Fedorko L,Stewart DJ,et al.Temporal relationship between endothelin-1 concentrations and cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage.Stroke,2001,32:1185-1190.
8Wickman G,Lan C,Vollrath B.Functional roles of the rho/rho kinase pathway and protein kinase C in the regulation of cerebrovascular constriction mediated by hemoglobin:relevance to subarachnoid hemorrhage and vasospasm.Circ Res,2003,92:809-816.
9Satoh M,Parent AD,Zhang J H.Inhibitory effect with antisense mitogen-activated protein kinase oligodeoxynucleotide against cerebral vasospam in rats.Stroke,2002,33:775 -781.
10Sampson LJ,Hinton JM,Garland CJ.Evidence for expression and function of phosphodiesterase type 5 (PDE-V) in rat resistance arteries.BrJ Pharmacol,2001,132:13 -17.
